Audience
Clinical-grade decision support system that provides doctors histopathology diagnosis of cancer
About Qritive
Making cancer diagnosis fast, accurate, and affordable. During our lifetime, 1 in 3 of us will get cancer. But cancer diagnosis is slow and expensive because doctors are not equipped with modern automated tools. Qritive provides an AI-powered solution to help doctors analyse both microscopy images and text from patient data. As a result, hospitals will be more efficient in making cancer diagnoses, allowing them to save costs. Pantheon is a CE marked vendor-agnostic digital pathology platform that enables digitization of the entire pathology lab workflow and telepathology, supports rich report generation, and provides a platform for AI analysis of pathology whole-slide images. Differentiates a wide range of benign diseases and malignancies in breast tissue.
Other Popular Alternatives & Related Software
Paige
Paige products can transform the way pathologists work by bringing confidence to diagnosis. Paige is on a mission to develop and deliver a new generation of clinical applications and predictive tests, empowering pathologists and transforming oncology. Our AI solutions provide a clear path into the future of pathology. The Paige Platform is a secure end-to-end solution that provides LIS interoperability, multi-scanner integration, cloud storage, case management, image review via FullFocus®, and powerful AI applications. Paige Prostate is a suite of AI applications created to assist pathologists in the detection of suspicious foci, grading and quantification of tissue, and an indication of perineural invasion (PNI) in needle core biopsy samples from the prostate tissue. Paige Breast is a suite of AI applications created to assist pathologists in breast cancer evaluation, providing the detection of cancer in breast biopsies and the detection of metastases in breast lymph nodes.
Learn more
Proscia
Concentriq, our AI-powered software platform sits at the intersection of digital and computational pathology, where functionality needed to carry out routine pathology operations connects with powerful AI applications to accelerate breakthroughs and improve patient outcomes. Laboratories worldwide recognize the challenges we all face today—a rising cancer burden, a shortage of pathologists, declining reimbursements, and the demands to rapidly modernize. However, with one billion pathology slides per year set to go digital, creating vast amounts of new data and information, the time to seize this moment is now. Digital pathology is giving today’s forward-thinking pathology organizations the means to overcome our collective challenges and fundamentally transform how we work and contribute to medicine and patient care.
Learn more
The Galen Platform
Ibex Medical Analytics is the pioneer in AI-powered cancer diagnostics in pathology. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision is transforming cancer diagnostics with AI and improving patient care. Pathologists are challenged to provide accurate and timely analysis as the number of tests increases every year. Ibex uses artificial intelligence (AI) to develop clinical-grade solutions that help detect cancer as accurately as a human pathologist. Galen Platform uses algorithms to analyze images, detect and grade cancer in biopsies and point to other findings with high clinical importance, helping pathologists reduce diagnostic error rates and enable a more efficient workflow. Ibex’s Galen™ Prostate and Galen™ Breast are the first-ever AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases.
Learn more
WRRisk
The product assigns a risk rating to a patient to drive a digital personalized screening plan for more consistent follow-up recommendations and more accurate diagnosis. This approach helps to catch cancers in the women that are at the greatest risk. WRRisk serves as a fully digital breast cancer risk assessment combining patient completed digital forms with a density assessment to provide a unified risk scorecard. WRRisk simplifies breast risk program maintenance by eliminating paper and automating many of the manual steps, from collecting forms to letter generation. The product equips patients and providers with the information they need. WRRisk Calculates 10-year and lifetime risk as well as risk-based on runner-up density.
Learn more
Integrations
No integrations listed.
Company Information
Qritive
Founded: 2017
Singapore
www.qritive.com
Videos and Screen Captures
Other Useful Business Software
Our Free Plans just got better! | Auth0
You asked, we delivered! Auth0 is excited to expand our Free and Paid plans to include more options so you can focus on building, deploying, and scaling applications without having to worry about your security. Auth0 now, thank yourself later.
Product Details
Platforms Supported
Cloud
Training
Live Online
Support
Online
